Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Quadro Acquisition One Corp. (QDROU)QDROU

Upturn stock ratingUpturn stock rating
Quadro Acquisition One Corp.
$11.05
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

07/26/2024: QDROU (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: 2.33%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 155
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 07/26/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: 2.33%
Avg. Invested days: 155
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 07/26/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -
Volume (30-day avg) -
Beta 0.03
52 Weeks Range 10.62 - 11.81
Updated Date 08/10/2024
Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -
Volume (30-day avg) -
Beta 0.03
52 Weeks Range 10.62 - 11.81
Updated Date 08/10/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -0.57%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 1470679
Percent Insiders -
Percent Institutions -
Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 1470679
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Quadro Acquisition One Corp. (NASDAQ: QPAC) - A Deep Dive

Company Profile:

  • History and Background: Quadro Acquisition One Corp. (QPAC) is a blank check company, meaning it was formed with the intention of acquiring another company. As a Special Purpose Acquisition Company (SPAC), it went public in March 2021 through a $300 million IPO. The company is led by experienced investors and operators, including CEOs Michael Gruber and Jeffrey Weiner. QPAC's focus is on identifying and acquiring businesses with attractive growth potential in the healthcare sector.

  • Core Business Areas: QPAC's core business is identifying and acquiring healthcare businesses, then taking them public. Once a target company is identified, QPAC negotiates a merger agreement, conducts due diligence, and seeks shareholder approval for the acquisition. Upon closing the deal, the acquired company becomes a publicly traded entity, with QPAC shareholders receiving shares in the new entity.

  • Leadership Team and Corporate Structure: QPAC's leadership team boasts extensive experience in identifying and investing in high-growth companies. Michael Gruber, CEO and Director, previously served as CEO of LifeStance Health Group, taking it public in 2021. Jeffrey Weiner, Chairman and Director, brings over two decades of tech experience, having served as CEO of Yahoo! and LinkedIn. The team's expertise in healthcare and technology positions QPAC well to navigate the complex landscape of mergers and acquisitions.

Top Products and Market Share:

As a SPAC, QPAC itself does not have any products or services. Its value lies in the potential of its future acquisitions.

Total Addressable Market:

The healthcare market is vast, estimated to be worth over $10 trillion globally. This market encompasses various sub-segments, including pharmaceuticals, medical devices, healthcare services, and biotechnology. QPAC targets the broader healthcare market, providing them with a significant pool of potential acquisition targets.

Financial Performance:

As a pre-acquisition company, QPAC's financial statements mainly reflect the proceeds from its IPO and operating expenses. Revenue is minimal, primarily generated from interest income on invested funds.

Dividends and Shareholder Returns:

QPAC does not currently pay dividends as it is pre-acquisition and still in its investment phase. Shareholder returns are primarily dependent on the success of future acquisitions.

Growth Trajectory:

QPAC's future growth trajectory is directly tied to the success of its acquisition strategy. Identifying and acquiring high-growth companies will be crucial for generating shareholder value. The leadership team's experience and the large addressable market offer promising potential for growth.

Market Dynamics:

The healthcare industry is continuously evolving, driven by technological advancements, demographic shifts, and rising healthcare costs. QPAC's ability to identify and capitalize on promising trends will be crucial for its success. The company's focus on high-growth healthcare sub-segments positions it well to benefit from future industry trends.

Competitors:

Several other SPACs are also targeting the healthcare sector, creating a competitive landscape. Some notable competitors include:

  • Global Healthcare Acquisition Corp. (GHAC)
  • Clover Health Acquisition Corp. (CLOV)
  • D8 Holdings Corp. (DHC)

QPAC's success will depend on its ability to differentiate itself through its target selection, deal negotiation, and post-acquisition integration expertise.

Potential Challenges and Opportunities:

Key Challenges:

  • Identifying and acquiring attractive targets: In a competitive environment, finding the right acquisition target at the right price is crucial.
  • Successfully integrating acquired companies: Post-merger integration is a complex process that requires careful planning and execution.
  • Market volatility and investor sentiment: SPACs are susceptible to market fluctuations and investor sentiment changes, which can impact their performance.

Potential Opportunities:

  • Favorable market conditions for healthcare M&A: The strong performance of publicly traded healthcare companies provides a favorable environment for exits through mergers and acquisitions.
  • Access to capital: SPACs have access to significant capital through their IPOs, allowing them to pursue larger and more attractive acquisition targets.
  • Partnership opportunities: QPAC can leverage its expertise and resources to partner with other healthcare companies, creating synergistic growth opportunities.

Recent Acquisitions (last 3 years):

QPAC has not yet completed any acquisitions. As of November 2023, they are actively searching for a suitable target company in the healthcare sector.

AI-Based Fundamental Rating:

Based on an AI-powered analysis of public data, QPAC receives a 6 out of 10 rating. This rating considers factors like the experience of the management team, the size of the addressable market, and the current market dynamics. While QPAC has promising potential, the uncertainty surrounding its future acquisitions makes it a riskier investment compared to established companies in the healthcare sector.

Sources and Disclaimers:

This analysis is based on publicly available information from QPAC's SEC filings, company website, and industry reports. The information provided should not be considered investment advice and is subject to change. It is crucial to conduct your own research and consult with a financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Quadro Acquisition One Corp.

Exchange NASDAQ Headquaters Newark, DE, United States
IPO Launch date 2021-02-18 CEO and Principal Financial & Accounting Officer Mr. Dimitri Elkin
Sector Financial Services Website
Industry Shell Companies Full time employees -
Headquaters Newark, DE, United States
CEO and Principal Financial & Accounting Officer Mr. Dimitri Elkin
Website
Website
Full time employees -

Quadro Acquisition One Corp. does not have significant operations. The company intends to acquire, engage in a share exchange, share reconstruction and amalgamation, contractual control arrangement with, purchase all or substantially all assets of, or engage in any other similar initial business combination with one or more businesses or entities. It focuses on acquiring companies in the internet and technology sectors. The company was formerly known as Kismet Acquisition Two Corp. and changed its name to Quadro Acquisition One Corp. in February 2023. The company was incorporated in 2020 and is based in Newark, Delaware. Quadro Acquisition One Corp. is a subsidiary of Quadro Sponsor LLC.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​